Efficacy and Safety of Favipiravir in Covid-19 Patients in Indonesia

NCT04613271 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

130

Enrollment

OTHER

Sponsor class

Conditions

Infectious Disease
SARS-CoV Infection
Covid19

Interventions

DRUG: Favipiravir
DRUG: Azithromycin

Sponsor

Ina-Respond

Collaborators

[object Object]